Header Logo

Connection

Lynette Rogers to Thioredoxin Reductase 1

This is a "connection" page, showing publications Lynette Rogers has written about Thioredoxin Reductase 1.
Connection Strength

0.744
  1. Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Am J Respir Cell Mol Biol. 2009 Nov; 41(5):612-9.
    View in: PubMed
    Score: 0.322
  2. Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia. Oxid Med Cell Longev. 2019; 2019:7945983.
    View in: PubMed
    Score: 0.160
  3. Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2018 05 01; 314(5):L736-L742.
    View in: PubMed
    Score: 0.149
  4. The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome. Antioxid Redox Signal. 2014 Jun 10; 20(17):2681-91.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.